Search clinical trials for: Kazakhstan

Total 206 results

Nazarbayev University
Ministry of Health, Kazakhstan

Completed

Physical and Chemical Study of Atherosclerosis Mechanisms (PCSAM)

Myocardial Infarction | Diabetes Mellitus, Type 2 | Atherosclerosis of Femoral Artery | Coronary Artery Diseases

Kazakhstan
Bayer

Completed

AVANTI - Avelox® in Acute Exacerbations of chroNic bronchiTIs

Bronchitis, Chronic

Slovakia, Kazakhstan, Macedonia, The Former Yugoslav Republic of, Moldova, Republic of, Russian Federation, Ukraine, Bosnia and Herzegovina, Albania
Bayer

Completed

Physical Activity and Fatigue in Early Multiple Sclerosis (MS) (BEGIN)

Multiple Sclerosis

Switzerland, France, Germany, Indonesia, Korea, Republic of, Spain, Sweden, Thailand, Taiwan, Australia, Austria, Colombia, Czech Republic, Italy, Jordan, Kazakhstan, Lebanon, Mexico, Slovenia, United Kingdom, Bahrain, Egypt, United... and more
Sanofi

Completed

Initiation and Titration of Amaryl (AMIT KZ)

Diabetes Mellitus, Type 2

Kazakhstan
Bayer

Completed

Use of Nebido® to Assess Tolerability and Treatment Outcomes in Daily Clinical Practice (IPASS Nebido)

Hypogonadism | Male

Germany, Indonesia, Korea, Republic of, Malaysia, Saudi Arabia, Singapore, Spain, Thailand, Philippines, Taiwan, Australia, Austria, Bulgaria, Colombia, Czech Republic, Estonia, Hong Kong, Italy, Jordan, Kazakhstan, Latvia, Lebanon, Lithuani... and more
Sanofi

Completed

APIDRA Registration Study

Diabetes Mellitus, Type 1

Kazakhstan

3

Subscribe